Sekisui Diagnostics

For 40 years SEKISUI Diagnostics has been committed to providing innovative medical diagnostics to physicians and lab... read more Featured Products:

Handheld Blood Glucose Analyzer

Respiratory Syncytial Virus Test

Flu SARS-CoV-2 Combo Test

COVID-19 Rapid Test

Group A Streptococcus Antigen Test

More products

Download Mobile App

Featured Links

Medical Equipment Marketplace
Visit our all new website Trademed.com where buyers and sellers can find the best medical device and equipment.

Sekisui Diagnostics Displays Full Range of Clinical Chemistry, Point-of-Care, and Biochemical Solutions

By HospiMedica International staff writers
Posted on 19 Nov 2025

At MEDICA 2025, Sekisui Diagnostics is presenting a broad lineup of in-vitro diagnostic products spanning clinical chemistry reagents, point-of-care testing solutions, enzymes and specialty biochemicals, biopharmaceutical services, and blood collection tube raw materials. More...

Exhibiting in Hall 1, Stand D57, the company draws on more than 40 years of global diagnostics expertise to support physicians, hospitals, laboratories, and decentralized testing environments.

At the booth, visitors can explore the OSOM rapid-test family, which provides fast, lateral-flow diagnostics for a wide range of infectious diseases, including influenza, Group A Strep, and Trichomonas vaginalis. For clinical chemistry, Sekisui is also highlighting its SEKURE reagent kits, which offer liquid-stable technology, strong performance, proven reliability, and comprehensive support services. Calibrators, controls, and linearity materials are also on display to complement instrument-based testing.

Sekisui is also prominently featuring point-of-care and home-testing solutions at MEDICA 2025. The OSOM brand extends into home-use products, including antigen- and molecular-based kits for COVID-19 and other respiratory pathogens. Sekisui also introduces its Metrix molecular platform and the Acucy diagnostic reader, both designed to support instrument-enabled point-of-care workflows in decentralized settings.

High-quality enzymes and specialty biochemicals form another key part of the portfolio, with products tailored for a variety of applications, including pharmaceutical manufacturing, clinical chemistry reagents, and POC/biosensor devices. The company is also highlighting its raw materials for plastic vacuum blood-collection tubes and related pre-analytic systems, which are trusted by blood-collection tube manufacturers worldwide. Sekisui’s raw materials offer excellent performance characteristics that support stable, reliable serum generation with very low influence on clinical test results, contributing to more accurate diagnostics and improved patient outcomes.

Latest Medica 2025 News

Channels

Artificial Intelligence

view channel

$Image: Mass General Brigham researchers developed two AI tools from one foundation model (called FAHR-Face) that can estimate biological age and predict cancer survival outcomes from a single face photo. The image on the left depicts the features most important to FAHR-FaceSurvival\'s predictions of cancer survival outcomes, while the image on the right shows the features most important to FAHR-FaceAge\'s estimates of biological age. Areas shown in yellow had the greatest influence on each model\'s predictions. (Photo courtesy of Mass General Brigham/Lancet Digital Health)$

$Image: Purdue University physicist David Nolte is developing a biodynamic imaging system that could improve the care of cancer patients undergoing chemotherapy. Nolte\'s system can rapidly evaluate the outcome of different chemotherapy drugs on patient biopsies (obtained during diagnosis), which could ensure patients get the chemotherapy treatment that would be most effective on their specific tumor. Right now, the system is being used at the Indiana University School of Medicine to evaluate the impact of experimental chemotherapy drugs on tumor cells derived from more than 30 osteosarcoma patients. It has also been used in clinical and preclinical trials. (IMage Credit: Purdue University/Kelsey Lefever)$

Optical Imaging System Helps Predict Chemotherapy Response in Cancer

Selecting chemotherapy can be difficult because tumors from different patients may respond differently to the same drug. Testing treatment effects directly on living tumor tissue could help clinicians... Read more

Critical Care

view channel

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Proposed Risk Score Prioritizes Sickest Patients for Heart Transplant

Donor hearts remain extremely scarce in the U.S. transplant system, with one in five candidates dying or being removed from the waiting list before receiving an organ. Current allocation rules may also... Read more

Wearable Robotic Gait Training Linked to Improved Walking Distance in ALS

Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that damages nerve cells controlling voluntary muscles. As the disease advances, patients can lose the ability to walk, speak,... Read more

Consumer Smartwatch May Expand Access to Obstructive Sleep Apnea Screening

Obstructive sleep apnea occurs when the upper airway becomes blocked during sleep, repeatedly stopping or restricting breathing. The disorder often goes undiagnosed, leaving untreated individuals at increased... Read more

Surgical Techniques

view channel

Combined Wound Healing Approach Pairs Synthetic Scaffold With Negative Pressure Therapy

Managing complex wounds requires both structural support for tissue repair and a controlled environment that protects the healing process. Frequent dressing changes can disrupt the wound bed and add complexity... Read more

Shape-Changing Hydrogels Show Promise for Tissue Engineering and Wound Healing

Human tissues often have complex three-dimensional shapes that are closely tied to their function, but recreating these curvatures remains challenging in tissue engineering and wound repair.... Read more

$Image: The new technology uses augmented reality to overlay a 3D visualization of the tumor and other anatomical structures on the surgeon\'s camera view. Here, Niclas Kvarnström, transplant surgeon and head of the Transplant Centre, and Fatuma Shieriye, specialist physician, perform the first operation using the new technology. (Image Credit: Jenny Cedås)$